NCT07210658 is a NA clinical trial of Oral nutritional supplementation in Paediatrics, sponsored by Société des Produits Nestlé (SPN).

Who is sponsoring NCT07210658?

NCT07210658 is sponsored by Société des Produits Nestlé (SPN).

What drugs are being tested in NCT07210658?

Interventions in NCT07210658: Oral nutritional supplementation.

What condition does NCT07210658 study?

NCT07210658 studies Paediatrics.

Is NCT07210658 still recruiting?

NCT07210658 is currently recruiting now. Last updated 9 January 2026.

Last reviewed 2026-01-09 · How we verify

NCT07210658

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acceptability, Gastrointestinal Tolerance, Compliance and Palatability Study.

Recruiting now NA Last updated 9 January 2026

What this trial tests

NA trial testing Oral nutritional supplementation in Paediatrics in 25 participants. Currently enrolling.

Timeline

14 April 2025

Primary endpoint
10 November 2025

15 May 2026

Quick facts

Lead sponsor	Société des Produits Nestlé (SPN)
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	25
Start date	14 April 2025
Primary completion	10 November 2025
Estimated completion	15 May 2026
Sites	1 location across United Kingdom

Drugs / interventions tested

Oral nutritional supplementation

Conditions studied

Paediatrics — all drugs for Paediatrics →

Sponsor

Société des Produits Nestlé (SPN) — full company profile →

Who can join

Adults 1 to 16, any sex, with Paediatrics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acceptability, compliance and palatability study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Oral nutritional supplementation

Trials testing the same drug.

NCT07058233 — Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: · NA · completed

Other Société des Produits Nestlé (SPN) trials

Trials by the same sponsor.

NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07210658 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
Last refreshed: 9 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07210658.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing